This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Alan D. Schreiber, MD

JAMA. 1982;248(11):1380-1385.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DURING the past decade, a number of studies have been performed in an attempt to improve our understanding of the factors responsible for the immunologic destruction of blood cells. These studies, which have used quantitative immunologic techniques, have led to an improved understanding of the pathophysiology of autoimmune hemolytic anemia and immune thrombocytopenic purpura, and to a more precise understanding of the effector mechanisms that are operable in immunohematologic disease. These studies have helped to identify those patients in clinical, but not yet in immunologic, remission and have helped in the treatment of those patients with persistent immunologic disease. Furthermore, these studies have helped to elucidate the mechanism of action of corticosteroids in immunohematologic disease and have enabled the clinician to diagnose more readily and monitor patients with immunohematologic disease. Additionally, these studies have led to an increased understanding of the pathophysiology of a new entity: immunologic infertility.

Immune Hemolytic . . . [Full Text PDF of this Article]

Author Affiliations
From the Hematology-Oncology Section, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.

Footnotes
Reprint requests to the Hematology-Oncology Section, Department of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104 (Dr Schreiber).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?